Aims and scope

Vascular Cell represents an open access medical journal which concentrates on publication of a wide range of topics related to the vascular system including neo-vascularization and angiogenesis. Since vascular endothelial cells represent a crucial factor in numerous pathological conditions such as: cancer, stroke, myocardial infarction or atherosclerosis their behavior is of paramount importance for the clinical outcomes of a wide range of patients.

In this context, Vascular Cell selects for publication the best experimental studies as well as clinical trials and case reports. Also, our journal publishes innovative molecular and immunohistochemistry protocols and methods, including quantitative digital pathology studies related to vascular pathways and factors. We are interested in studies describing the molecular mechanisms of vascular development as well as in vivo imaging experiments and clinical trials evaluating mediators interfering with angiogenesis. However, as angiogenesis represents a key player modulating tissue regeneration and 3D biological additive manufacturing, our journal publishes manuscripts reporting innovative research focusing on these topics. On a special note, Vascular Cell will particularly encourage the publication of inter- and trans-disciplinary studies validating concepts or hypotheses related to vascular cells physiopathology.


Topics of interest include, but are not limited to:

  • Molecular and cellular mechanisms of angiogenesis
  • Molecular and cellular mechanisms of vascular embryology
  • Angiogenesis and cancer
  • Angiogenesis and cardiovascular pathology
  • Angiogenesis and cerebral stroke
  • Angiogenesis and neurodegenerative diseases
  • Angiogenesis, tissue regeneration including wound healing and 3 D additive biological manufacturing
  • Angiogenesis and inflammation
  • Angiogenesis and diabetes mellitus
  • Pathologies related to vascular system (blood, bone, muscle etc.)
  • Imaging methods and protocols related to vascular system
  • Immunohistochemistry related to vascular markers
  • Clinical studies related to anti- or pro-angiogenic factors
  • Case presentation focusing on a rare vascular entity

About our affiliations

The Australasian Immunohistochemistry Society (AIS)

The Australasian Immunohistochemistry Society (AIS) ( fully endorses Vascular Cell. The Australasian Immunohistochemistry Society (AIS) represents a hub of knowledge aiming to advance knowledge by the collaborative effort of experts from all areas of biomedical sciences and histopathology with interest in diagnostic and research immunohistochemistry. The Australasian Immunohistochemistry Society (AIS) supports the progress in the filed through its regular international workshops and scientific meetings (

Members of The Australasian Immunohistochemistry Society (AIS) will receive a 10% discount on Vascular Cell's article-processing charge when they provide a discount code (which members can obtain by emailing the Australasian Immunohistochemistry Society) during the submission process.

North American Vascular Biology Organization (NAVBO)

Vascular Cell is affiliated with the North American Vascular Biology Organization (NAVBO). The purpose of the Society is to provide a forum whereby members disseminate and share knowledge related to the scientific field of vascular biology, to ensure the translation of knowledge from basic science to clinical practice. NAVBO supports and organizes meetings and workshops, and maintains an interactive website linking the vascular biology community.

Members of NAVBO will receive a 10% discount on Vascular Cell's article-processing charge when they provide a discount code (which members can obtain by emailing NAVBO) during the submission process.

Open access

All articles published by Vascular Cell are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers.

As an open access journal, Vascular Cell then asks authors to choose one of two Creative Commons licenses, each of which allows readers to reuse the published content in specific ways. The CC BY-NC license allows readers to distribute, adapt, or reuse articles for non-commercial purposes, while commercial reuse requires permission. The CC BY license allows readers to distribute, adapt, or reuse articles, including for commercial purposes.

As authors of articles published in Vascular Cell you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the 'Vascular Cell license agreement'.